Hanger (HNGR) Lifted to "Strong-Buy" at Zacks Investment Research  Caroline Horne | Aug 17th, 2018
Hanger (OTCMKTS:HNGR) was upgraded by Zacks Investment Research from a "hold" rating to a "strong-buy" rating in a research report issued on Wednesday. The brokerage currently has a $19.00 price objective on the healthcare company's stock. Zacks Investment Research 's price target suggests a potential upside of 12.63% from the stock's current price.
According to Zacks, "Hanger, Inc. delivers orthotic and prosthetic patient care, and distributes O&P products and rehabilitative solutions. The company's products & services segment provides Hanger distributes branded and private label O&P devices, products and components and provides rehabilitative solutions. Hanger Inc., formerly known as Hanger Orthoped, is based in AUSTIN, Texas. " Get Hanger alerts:
Separately, ValuEngine lowered Hanger from a "buy" rating to a "hold" rating in a report on Monday.
Shares of HNGR opened at $16.87 on Wednesday. The firm has a market cap of $612.34 million, a PE ratio of 51.12 and a beta of 4.13. The company has a current ratio of 1.86, a quick ratio of 1.41 and a debt-to-equity ratio of -14.28. Hanger has a one year low of $10.87 and a one year high of $19.50.
Hanger (OTCMKTS:HNGR) last issued its quarterly earnings results on Thursday, August 9th. The healthcare company reported $0.28 EPS for the quarter, missing analysts' consensus estimates of $0.33 by ($0.05). The firm had revenue of $266.97 million during the quarter, compared to the consensus estimate of $265.58 million. sell-side analysts anticipate that Hanger will post 0.79 EPS for the current year.
About Hanger
Hanger, Inc provides orthotic and prosthetic (O&P) patient care services; and distributes O&P devices, manages O&P networks, and provides therapeutic solutions to patients and businesses in acute, post-acute, and clinic settings in the United States. It operates in two segments, Patient Care and Products & Services.
Get a free copy of the Zacks research report on Hanger (HNGR)
For more information about research offerings from Zacks Investment Research, visit Zacks.com Receive News & Ratings for Hanger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hanger and related companies with MarketBeat.com's FREE daily email newsletter . Ã‚